Intelligence Profile
Clinical Applications
Salmon Protein Hydrolysate (SPH) has been explored for various clinical applications primarily relating to its anti-inflammatory and metabolic benefits.
Anti-inflammatory Benefits:
A study in the International Journal of Biological Macromolecules suggests that SPH derived from salmon head has notable anti-inflammatory properties. This points toward its potential use in managing inflammatory conditions, although more clinical data are needed to confirm these effects in humans.
Energy and Inflammation Modulation:
A completed Phase 1 clinical trial (NCT03535571) evaluated SPH's efficacy in increasing energy and modulating inflammation in healthy individuals. The findings support its potential role in promoting general well-being and reducing inflammation, but further studies are needed to establish these benefits more comprehensively.
Metabolic and Hematologic Health:
Another completed study (NCT07616752) focused on SPH supplementation's impact on metabolic and hematologic health. The results indicate possible improvements in metabolic functions and blood health, suggesting uses in supporting metabolism and possibly addressing certain anemias, although specifics on the degree of impact were not detailed.
Overall, while initial studies show promising applications of SPH in anti-inflammatory and metabolic health contexts, more extensive clinical trials are necessary to better understand its efficacy and safety.
Disclaimer: This information is intended for informational purposes only and should not be considered as personalized medical advice. Always consult a healthcare provider for medical guidance specific to your needs.